“…F-actin cytoskeletal plasticity is required for vesicular trafficking (Doussau and Augustine, 2000;Morales et al, 2000;Trifaro et al, 2002), dendritic motility (Matus, 2000), and the maintenance phase of LTP (Kim and Lisman, 1999;Krucker et al, 2000;Fukazawa et al, 2003). MARCKS binds and crosslinks F-actin in a PKC phosphorylation-dependent manner (Hartwig et al, 1992;Bubb et al, 1999;Yarmola et al, 2001), and PKC-mediated phosphorylation of MARCKS results in the movement of synaptic vesicles from reserve pools to active release sites in cultured cells and synaptosomes (Vitale et al, 1995;Stevens and Sullivan, 1998;Walaas and Sefland, 2000;Rose et al, 2001;Yang et al, 2002). Furthermore, anti-MARCKS antibodies, or F-actin destabilizing agents, increase spontaneous neurotransmitter release in PC12 cells (Shoji-Kasai et al, 2002), whereas MARCKS overexpression (two-fold) impaired PKCinduced enhancement of neurotransmitter release in human neuroblastoma SH-SY5Y cells (Hartness et al, 2001).…”